10.1.4. summary evidence recommendations treatment ischaemic priapism. summary evidenceleischaemic priapism medical emergency immediate intervention mandatory.2berectile function preservation directly related duration ischaemic priapism, age andpre-operative erectile status.2bmedical treatment variably effective case priapism lasting less 48 hours.2baspiration ± irrigation 0.9% results 80% success rate combined intracavernous injection sympathomimetic drugs.2bphenylephrine recommended drug due favourable safety profile cardiovascular system compared drugs. phenylephrine usually diluted normal saline concentration 100-500 μg/ml given 200 μg doses every three five minutes directly corpus cavernosum. maximum dosage 1 mg within one hour. patient monitoring highly recommended.2boral terbutaline success rate 60% cases priapism associated intracavernous injection erectogenic agents.1bexchange transfusion patients priapism associated scd may result serious neurological sequelae.2bshunt procedures effective resolve priapism provide pain relief. clear recommendation superiority one type shunt another given. distal shunts less invasive associated lower rate erectile dysfunction.2bperi- post-operative anticoagulant prophylaxis (325 mg acetylsalicylic acid pre-operatively, 5,000 iu heparin intra-operatively 81 mg acetylsalicylic acid 75 mg clopidogrel five days post-operatively) may prevent priapism recurrence.3erectile dysfunction almost inevitable prolonged cases ischaemic priapism. early implantation penile prosthesis associated lower infection rates complications compared late implantation.2b recommendationsstrength ratingstart management ischaemic priapism early possible (within four six hours) follow stepwise approach.strongdecompress corpus cavernosum penile aspiration washout fresh red blood obtained first treatment step.strongreplace blood aspiration intracavernous injection sympathomimetic drug first step priapism secondary intracavernous injections vasoactive agents.strongperform intracavernous injection sympathomimetic drug priapism persists despite aspiration.strongrepeat aspiration intracavernous injection sympathomimetic drug cases persist despite prior aspiration intracavernous injection sympathomimetic drug, considering surgical intervention.strongtreat ischaemic priapism associated sickle cell disease fashion idiopathic ischaemic priapism. use exchange transfusion primary treatment. provide supportive measures (intravenous hydration, oxygen administration alkalisation bicarbonate, blood exchange transfusions), delay initial treatment penis.strongproceed surgical treatment blood aspiration intracavernous injection sympathomimetic drugs failed.strongperform distal shunt surgical procedures first combine tunnelling necessary.weakuse proximal procedures cases distal shunt failure (< 48 hours) patients wish proceed immediate penile implant insertion.weakdiscuss implantation penile prosthesis cases delayed presentation (> 48 hours) cases refractory injection therapy distal shunting.weakdelay implantation penile prosthesis shunt performed, minimise risk infection erosion implant.strongdecide type implant insert based on:patient suitability;surgeons’ experience; andavailability cost equipment.if malleable penile prosthesis implanted exchanged later inflatable penile implant.strong